aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 16, 2017 · 10-K · 75 days after period end · 0001564590-17-004631
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Net Income | -$12.57M | -$16.49M | -$6.04M |
| EPS Diluted | -$0.53 | -$0.70 | -$7.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 16, 2017 · 75 d after period end
